Opportunity ID: 49073

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-09-026
Funding Opportunity Title: The Biology of Estrogen Receptor-Negative Breast Cancer in Various Racial and Ethnic Groups (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.396 — Cancer Biology Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 13, 2009
Last Updated Date:
Original Closing Date for Applications: Jan 05, 2010
Current Closing Date for Applications: Jan 05, 2010
Archive Date: Feb 05, 2010
Estimated Total Program Funding: $2,000,000
Award Ceiling: $667,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
County governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose.The purpose of this funding opportunity announcement (FOA) is to promote the systematic study of the biology of estrogen receptor (ER)-negative human breast cancers, the characterization of their molecular features, the signaling pathways and networks that support their growth, as well as to identify differences in the biology of ER-negative breast tumors among racial and ethnic groups. The information will be crucial in developing early detection and intervention strategies. This initiative will support studies on: the basic biology of ER-negative breast cancers and delineation of differences that exist between ER-positive and ER-negative breast cancers; the identification of the subtypes or heterogeneity that exist within ER-negative breast cancers; and the determination of whether the biology of ER-negative breast tumors differs across racial and ethnic groups. In order to address these goals, the National Cancer Institute (NCI) solicits applications from collaborative teams of interdisciplinary investigators focused on characterizing the biologic drivers, including genetic, epigenetic, molecular, and cellular factors, of ER-negative human breast cancer development and progression.
Mechanism of Support. This FOA will utilize the NIH U01 cooperative agreement mechanism.
Funds Available and Anticipated Number of Awards. The NCI expects to commit approximately $10 million for 5 years to fund up to three awards.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-10T15:31:55-05:00

Share This Post, Choose Your Platform!

About the Author: